Four UCPH Projects Receive Government Grants for Corona Research
The government has allocated DKK 50 million to conduct research into coronavirus in order to quickly obtain new knowledge and solutions in the fight against COVID-19. Four research projects from the University of Copenhagen have been selected and will receive funding from the government.
Last week, the Danish government decided to earmark DKK 50 million for coronavirus research after the infection has come to Europe and now is spreading in the Danish society.
Minister for Higher Education and Research Ane Halsboe-Jørgensen and Minister for Health Magnus Heunicke have selected nine research projects that will each be receiving between DKK 970,000 and 13 million. University of Copenhagen researchers are represented in four of the projects.
‘We have some of the world's leading researchers in Denmark, and I am impressed with the commitment in the fight against coronavirus. I have high hopes that the researchers can come up with results that can benefit patients and help us to utilise the capacity in our healthcare system in the best possible way’, says Minister for Higher Education and Research Ane Halsboe-Jørgensen in a press release from the Ministry.
The Danish Agency for Science and Higher Education has received 31 applications from research projects, of which, as mentioned, nine will be receiving support.
‘I hope that the projects will soon provide us with valuable research results that can help us to cope with some of the challenges we are facing with COVID-19. The epidemic can put our healthcare system, the staff and all of us in an exceptionally difficult situation, so we must act now. The projects have great potential for, among other things, advancing a better treatment of the patients and strengthening the healthcare system's ability to cope with the stress which the epidemic has created at the hospitals. I look forward to following the researchers’ work’, says Minister for Health Magnus Heunicke in the press release.
Read more about the four UCPH projects below:
This is a randomised study of treatment of hospitalised patients with COVID-19. The project has an international scope and investigates the possibility of treating hospitalised patients with COVID-19, where the disease has developed into severe pneumonia. The project will investigate treatment options including Remdisivir that was developed to treat other viruses. The trial will treat already admitted patients with known antiviral products and the aim is for COVID-19 patients to be treated quickly and on the basis of an already known side effect profile.
The project investigates the prevalence of relatively mild COVID-19 courses in children and adolescents, aged 0-17. The project will map the clinical and immunological host responses of the group and will identify different levels of immune stimulating or suppressive cytokines in order to subsequently to be able to medically target the treatment and thus facilitate the course of the disease in severely affected patients of all ages.
The project is investigating the possibility of treating COVID-19 with already known anti-viral drugs. The trial will treat hospitalised patients with known antiviral compounds that inhibit replication of COVID-19, thus ensuring that current COVID-19 patients can be treated quickly and based on an already known side effect profile.
The project will investigate the impact of COVID-19 on pregnant women, foetuses and new-born babies using collected samples that may determine the possible genetic impact of the infection. The project may provide a foundation for evidence-based counselling for pregnant women.